These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20529796)

  • 21. Diagnosis and management of anaphylaxis.
    Ellis AK; Day JH
    CMAJ; 2003 Aug; 169(4):307-11. PubMed ID: 12925426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic and nonallergic delayed infusion reactions during natalizumab therapy.
    Hellwig K; Schimrigk S; Fischer M; Haghikia A; Müller T; Chan A; Gold R
    Arch Neurol; 2008 May; 65(5):656-8. PubMed ID: 18474743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypersensitivity reaction to paclitaxel: nursing interventions.
    Myers JS
    Clin J Oncol Nurs; 2000; 4(4):161-3. PubMed ID: 11261096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous reactions associated with alpha interferon therapy.
    Stafford-Fox V; Guindon KM
    Clin J Oncol Nurs; 2000; 4(4):164-8. PubMed ID: 11261097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular side effects of chemotherapy: nursing management.
    Cloutier AO
    Oncol Nurs Forum; 1992 Sep; 19(8):1251-9. PubMed ID: 1408967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infusion reactions triggered by monoclonal antibodies treating solid tumors.
    Carney PH; Ollom CL
    J Infus Nurs; 2008; 31(2):74-83. PubMed ID: 18344767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid desensitization for hypersensitivity reactions to medications.
    Castells M
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):585-606. PubMed ID: 19563999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin desensitization.
    Choi J; Harnett P; Fulcher DA
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Incidence and Management of Hypersensitivity and Infusion Reactions in an Outpatient Chemotherapy Center].
    Sekine H; Akaiwa A; Onozawa Y; Kinjo T; Nakamura H; Nakamura R; Nawa M; Yoshida S; Araki N; Iizuka M; Shimizu H; Sunaga N; Tsukamoto N
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1625-1629. PubMed ID: 30449851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maculopapular skin rashes associated with high-dose chemotherapy: prevalence and risk factors.
    Wright LG
    Oncol Nurs Forum; 2006 Nov; 33(6):1095-103. PubMed ID: 17149393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
    Schwartz JR; Bandera C; Bradley A; Brard L; Legare R; Granai CO; Dizon DS
    Gynecol Oncol; 2007 Apr; 105(1):81-3. PubMed ID: 17157366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular toxicity associated with cancer treatment.
    Viale PH; Yamamoto DS
    Clin J Oncol Nurs; 2008 Aug; 12(4):627-38. PubMed ID: 18676329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do Corticosteroids Prevent Biphasic Anaphylaxis?
    Alqurashi W; Ellis AK
    J Allergy Clin Immunol Pract; 2017; 5(5):1194-1205. PubMed ID: 28888249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
    Viale PH
    Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylaxis: implications of monoclonal antibody use in oncology.
    Gleich GJ; Leiferman KM
    Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):7-13. PubMed ID: 19385161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization.
    Breslow RG; Caiado J; Castells MC
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
    Esper P; Gale D; Muehlbauer P
    Clin J Oncol Nurs; 2007 Oct; 11(5):659-66. PubMed ID: 17962174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.